A strong association is observed between circulating aCL IgG antibodies and non-thrombotic cardiac manifestations, including CAD, aortic/mitral/tricuspid regurgitation, mitral valve prolapse, and cardiomyopathy [76]. This evidence concerns the gene ACLY and mitral valve prolapse.